These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16375248)

  • 21. Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods.
    Zacharis CK; Tzanavaras PD
    J Pharm Biomed Anal; 2008 Nov; 48(3):483-96. PubMed ID: 18599247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A risk-based analysis of the AAPS conference report on quantitative bioanalytical methods validation and implementation.
    Boulanger B; Rozet E; Moonen F; Rudaz S; Hubert P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2235-43. PubMed ID: 19577965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasensitive assay of clindamycin in medicine and bio-fluids with chemiluminescence detection.
    Wei G; Dang G; Li H
    Luminescence; 2007; 22(6):534-9. PubMed ID: 17768707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strength and honor through the pharmaceutical industry's embrace of green chemistry?
    Fortunak J; Confalone PN; Grosso JA
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):651-3. PubMed ID: 17987518
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of an in-capillary approach to nanoscale automated in vitro cytochromes p450 assays.
    Nicoli R; Curcio R; Rudaz S; Veuthey JL
    J Med Chem; 2009 Apr; 52(8):2192-5. PubMed ID: 19326942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(106):32105-6. PubMed ID: 16795933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can medication be taken after the expiration date?
    Health News; 2005 Nov; 11(11):16. PubMed ID: 16299863
    [No Abstract]   [Full Text] [Related]  

  • 28. Environmental and pharmaceutical analysis of dithiocarbamates.
    Szolar OH
    Anal Chim Acta; 2007 Jan; 582(2):191-200. PubMed ID: 17386492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-based assays in GPCR drug discovery. In this issue.
    Biotechnol J; 2008 Apr; 3(4):430. PubMed ID: 18412181
    [No Abstract]   [Full Text] [Related]  

  • 30. Polysaccharides as source of advanced and sustainable products.
    Boeriu CG
    Carbohydr Polym; 2013 Mar; 93(1):1. PubMed ID: 23465893
    [No Abstract]   [Full Text] [Related]  

  • 31. Editorial: Novel approaches to drug discovery in signal transduction.
    Dekker L
    Biotechnol J; 2008 Apr; 3(4):428-9. PubMed ID: 18412180
    [No Abstract]   [Full Text] [Related]  

  • 32. Development and validation of a quantitative cell-based bioassay for comparing the pharmacokinetic profiles of two recombinant erythropoietic proteins in serum.
    Wei X; Grill DS; Heatherington AC; Swanson SJ; Gupta S
    J Pharm Biomed Anal; 2007 Jan; 43(2):666-76. PubMed ID: 16971087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The matrix reloaded: Halozyme's recombinant enzyme helps injected drugs spread faster.
    Shekhar C
    Chem Biol; 2007 Jun; 14(6):603-4. PubMed ID: 17584606
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the recovery spread in analytical development and routine quality control--based on the ICH quality guideline Q2B.
    Schepers U; El Deeb S; Ermer J; Wätzig H
    J Pharm Biomed Anal; 2007 Jan; 43(2):708-10. PubMed ID: 16904281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach.
    Vergote V; Burvenich C; Van de Wiele C; De Spiegeleer B
    J Pept Sci; 2009 Nov; 15(11):697-710. PubMed ID: 19750489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
    Miller CP; Ullrich JW
    Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-of-flight secondary-ion mass spectrometry for the surface characterization of solid-state pharmaceuticals.
    Prestidge CA; Barnes TJ; Skinner W
    J Pharm Pharmacol; 2007 Feb; 59(2):251-9. PubMed ID: 17270078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Theme issue "Solid state and solid dosage forms".
    Kleinebudde P
    Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of FT-NIR for API content assay in organic solvent media: a single calibration for multiple downstream processing streams.
    Rodrigues LO; Cardoso JP; Menezes JC
    Talanta; 2008 Jun; 75(5):1203-7. PubMed ID: 18585202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of an analytical procedure--control of residual solvents in pharmaceutical substance.
    Groman A; Kamieńska-Duda A
    Acta Pol Pharm; 2008; 65(6):783-7. PubMed ID: 19172868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.